Stiolto Respimat 2.736 ug/1

Stiolto Respimat 2.736 ug/1 is a combination inhaler containing tiotropium bromide and olodaterol. It is designed for respiratory use to help manage chronic obstructive pulmonary disease (COPD) symptoms. This metered spray delivers precise doses for effective inhalation therapy.

Stiolto Respimat 2.736 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It combines tiotropium bromide, a long-acting anticholinergic, and olodaterol, a long-acting beta-agonist, to improve lung function and reduce symptoms like wheezing and shortness of breath. This medication is often prescribed to individuals with COPD to help them breathe more easily and maintain their daily activities.

Common effects of Stiolto Respimat 2.736 ug/1 may include dry mouth, throat irritation, and cough. Some users might experience headaches or muscle spasms. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider.

Stiolto Respimat 2.736 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to avoid potential side effects. Patients with a history of heart conditions, high blood pressure, or seizures should use this medication with caution. Always store the inhaler properly and keep it out of reach of children.

Stiolto Respimat 2.736 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, avoid using this inhaler with other long-acting beta-agonists unless directed by a healthcare professional.